Illumina, Inc. (ILMN) — Stock Price, Chart & Analysis
Illumina, Inc. (ILMN) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $28.38B and a trailing P/E ratio of 35.07. Over the past 52 weeks, ILMN has traded between $88.00 and $207.00. Illumina, Inc. does not currently pay a regular dividend. View the live ILMN chart, technical opinion, analyst ratings, fundamentals and latest news below.
Illumina, Inc. (ILMN) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $28.38B |
| P/E ratio (TTM) | 35.07 |
| EPS (TTM) | $5.36 |
| 52-week high | $207.00 |
| 52-week low | $88.00 |
| Beta | 1.46 |
| Avg. volume | 2.02M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Frequently asked questions about Illumina, Inc. (ILMN)
How much does one share of Illumina, Inc. cost?
As of the latest update, one share of Illumina, Inc. (ILMN) trades at $100 (+0.00% today).
What is Illumina, Inc.'s market cap?
Illumina, Inc. has a market capitalization of approximately $28.38B.
What is Illumina, Inc.'s P/E ratio?
Illumina, Inc. has a trailing price-to-earnings (P/E) ratio of 35.07.
What is Illumina, Inc.'s earnings per share (EPS)?
Illumina, Inc.'s trailing twelve-month EPS is $5.36.
Does Illumina, Inc. pay a dividend?
Illumina, Inc. does not currently pay a regular dividend.
What is Illumina, Inc.'s 52-week trading range?
Over the past year, ILMN has traded between $88.00 and $207.00.
What is the analyst price target for Illumina, Inc.?
The mean analyst price target for Illumina, Inc. is $195.83. This is informational only and not investment advice.
Latest Illumina, Inc. (ILMN) news
- Illumina (ILMN) Q2 2026 Earnings Call TranscriptNews · Aug 4, 2026
- Illumina, Inc. (ILMN) Hits Fresh High: Is There Still Room to Run?News · Aug 3, 2026
- Why Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Outlook On Clinical SequencingNews · Aug 3, 2026
- Can Illumina (ILMN) Hold Its Price As Cash Flow And Earnings Clash?News · Aug 2, 2026
- Illumina (ILMN) Could Be 19% Overvalued Following Its Q2 Beat And Guidance RaiseNews · Aug 2, 2026
- Illumina Q2 Earnings Call HighlightsNews · Aug 1, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ILMN dashboard…